PipelineReview.com - Vaccines

Show Cart

Vaccines

Results 11 - 19 of 19

Dec 2012 Competitor Analysis: Herpes Virus Vaccines and Therapeutics

Oct 2012 Competitor Analysis: Pneumococcal and Streptococcal Vaccines

Sep 2012 Competitor Analysis: Tuberculosis Vaccines and Therapeutics

Aug 2012 Competitor Analysis: Malaria Vaccines & Therapeutics

Aug 2012 Competitor Analysis: CMV Vaccines and Therapeutics

May 2012 Competitor Analysis: Pseudomonas aeruginosa Vaccines and Therapeutics

Oct 2011 Competitor Analysis: HIV Vaccines

Jun 2011 Competitor Analysis: Hepatitis Vaccines

May 2011 Competitor Analysis: Influenza Vaccines

Start
Prev
1
2
Next
End

Shopping cart

Cart empty

Latest report

Cadherin 17: A target opportunity to develop effector-enhanced drug modalities

Featured Products

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Masked Antibodies & Cytokines As Prodrugs:a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

Latest Target Pipeline

Claudin 6: A target opportunity to develop effector-enhanced drug modalities

Shopping cart

Cart empty

Latest report

Cadherin 17: A target opportunity to develop effector-enhanced drug modalities

Featured Products

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Masked Antibodies & Cytokines As Prodrugs:a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

Latest Target Pipeline

Claudin 6: A target opportunity to develop effector-enhanced drug modalities

La Merie Biologics

FREE Weekly News Bulletin

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing